$1.5M SBIR Phase II Awarded for Nanobind Development

September 25, 2015

Circulomics has been awarded a $1.5M Phase II SBIR grant by the National Institutes of Health (NIH) - National Institute of General Medical Sciences (NIGMS) to create a comprehensive DNA and RNA extraction product portfolio based on the Nanobind technology first developed in Phase I.

 

press release has been issued with additional details. Circulomics receives coverage on GenomeWeb.

 

 

 

 

 

Share on Facebook
Share on Twitter
Please reload

Featured Posts

NIH Awards $1.5M SBIR Phase II Grant to Build PicoSep System to Analyze Nucleic Acid Sample Quality

February 7, 2017

1/2
Please reload

Recent Posts
Please reload

Archive